Alzheimer's disease in Brazil: an epidemiological analysis between 2013 and 2022




Alzheimer's disease; Epidemiology; Health of the elderly.


Objective: To describe the epidemiological profile of Alzheimer's disease in Brazil between 2013 and 2022. Methods: This is an exploratory, time-series study of epidemiological data on Alzheimer's disease in the Brazilian population. Data were obtained through the SUS Information System (DATASUS). Results: It was verified that there were 14,024 hospitalizations due to Alzheimer's Disease in Brazil between January 2013 and December 2022 and the most confirmed Brazilian region was the Southeast. In addition, it was possible to observe that the most trained age group was 80 years or older, with 8,168 cases, followed by the population aged 70 to 79 years, with 4,061 hospitalizations. With regard to sex and color, white women were the most affected. There were 152,891 deaths, most of which occurred in the southeastern region of the country. The average hospital stay rate was 22.9 days, the average hospital stay was R$ 1,754.75 and the total amount spent on Alzheimer's in the analyzed period was R$ 24,608,616.49. Conclusion: In short, it is possible to infer that Alzheimer's disease has a high incidence in Brazil, especially in the Southeast region. Female patients, white, aged 70 years or older are the most dependent. Despite being a disease of late onset in most cases, it causes damage to the quality of life of patients, as it causes impairment of higher cognitive functions, especially loss of memory of recent events.


Atri A. (2019). The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. The Medical clinics of North America, 103(2), 263–293.

Breijyeh, Z., & Karaman, R. (2020). Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules (Basel, Switzerland), 25(24), 5789.

Cummings, J. L., Tong, G., & Ballard, C. (2019). Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options. Journal of Alzheimer's disease: JAD, 67(3), 779–794.

DATASUS (2023). Departamento de Informática do SUS.

Eratne, D., Loi, S. M., Farrand, S., Kelso, W., Velakoulis, D., & Looi, J. C. (2018). Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis. Australasian psychiatry: bulletin of Royal Australian and New Zealand College of Psychiatrists, 26(4), 347–357.

Erkkinen, M. G., Kim, M. O., & Geschwind, M. D. (2018). Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor perspectives in biology, 10(4), a033118.

Garre-Olmo J. (2018). Epidemiologia de la enfermedad de Alzheimer y otras demencias [Epidemiology of Alzheimer's disease and other dementias]. Revista de neurologia, 66(11), 377–386.

Grabher B. J. (2018). Effects of Alzheimer Disease on Patients and Their Family. Journal of nuclear medicine technology, 46(4), 335–340.

Hodson R. (2018). Alzheimer's disease. Nature, 559(7715), S1.

Instituto Brasileiro de Geografia e Estatística. (2023). Projeção da população do Brasil e das Unidades da Federação. IBGE.

Khan, S., Barve, K. H., & Kumar, M. S. (2020). Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. Current neuropharmacology, 18(11), 1106–1125.

Kumar, A., Sidhu, J., Goyal, A., Tsao, J. W & Doerr, C. (2022). Doença de Alzheimer (Enfermagem). Em StatPearls. Publicação StatPearls.

Knapskog, AB, Engedal, K., Selbæk, G., & Øksengård, AR (2021). Alzheimers sykdom – diagnostikk og behandling [doença de Alzheimer – diagnóstico e tratamento]. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke, 141 (7), 10.4045/tidsskr.20.0919.

Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021). Alzheimer disease. Nature reviews. Disease primers, 7(1), 33.

Marconi, A. & Lakatos, E. M. (2021). Fundamentos de Metodologia Científica. (9a ed.), Editora Atlas, 2021.

Morley, J. E., Farr, S. A., & Nguyen, A. D. (2018). Alzheimer Disease. Clinics in geriatric medicine, 34(4), 591–601.

Tecalco-Cruz, A. C., Ramírez-Jarquín, J. O., Alvarez-Sánchez, M. E., & Zepeda-Cervantes, J. (2020). Epigenetic basis of Alzheimer disease. World journal of biological chemistry, 11(2), 62–75.

Tinetti, M. E., McAvay, G. J., Murphy, T. E., Gross, C. P., Lin, H., & Allore, H. G. (2012). Contribution of individual diseases to death in older adults with multiple diseases. Journal of the American Geriatrics Society, 60(8), 1448–1456.

Wong W. (2020). Economic burden of Alzheimer disease and managed care considerations. The American journal of managed care, 26(8 Suppl), S177–S183.

Zhang, X. X., Tian, Y., Wang, Z. T., Ma, Y. H., Tan, L., & Yu, J. T. (2021). The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention. The journal of prevention of Alzheimer's disease, 8(3), 313–321.



How to Cite

ARAÚJO, S. R. M. .; CUNHA, E. R. .; MARQUES, I. L. .; PAIXÃO, S. A. .; DIAS, A. de F. G. .; SOUSA, P. M. de .; SOARES, N. de K. P. .; SOUSA, M. O. .; LOBATO, R. M. .; SOUZA, M. T. P. de . Alzheimer’s disease in Brazil: an epidemiological analysis between 2013 and 2022. Research, Society and Development, [S. l.], v. 12, n. 2, p. e29412240345, 2023. DOI: 10.33448/rsd-v12i2.40345. Disponível em: Acesso em: 29 may. 2024.



Health Sciences